Riskpilot← Back to searchSign inGet full accessLittle Green Pharma Denmark ApS
APSActiveCVR 38947737Grønnegyden 105Growing of spices, aromatic, drug and pharmaceutical crops · NACE 0128Est. 201751 employees
Revenue 2025
DKK 41,9M
+106% vs 2024
EBITDA margin
42.3%
+34% vs 2024
Equity ratio
39.6%
Financial strength
Net profit 2025
DKK 32,1M
+301% vs 2024
| Revenue | DKK 41,9M | +106% |
| EBITDA | DKK 17,7M | +34% |
| Net profit | DKK 32,1M | +301% |
| Total assets | DKK 265,4M | +12% |
| Equity | DKK 105M | +40% |
| Employees | 51 | — |
Legal name
Little Green Pharma Denmark ApS
CVR number
38947737
Legal form
Anpartsselskab
NACE code
0128 · Growing of spices, aromatic, drug and pharmaceutical crops
Founded
20. september 2017
Share capital
DKK 304.382
Employees
51 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-03-31
Financial year
January – December
Signatory rights
Selskabet tegnes af formanden for bestyrelsen, af en direktør og et bestyrelsesmedlem i forening, af to medlemmer af bestyrelsen i forening eller af den samlede bestyrelse i forening.
Company purpose
Virksomhedens formål er produktion, import, eksport og handel samt andre dermed efter direktionens skøn beslægtede formål.
Address
Grønnegyden 105
Phone
+4566145070
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | -253.679 | -57.864 | 117.697 | 20.357 | 41.918 |
| Staff expenses | -0 | -32.382 | -22.299 | -0 | -24.201 |
| EBITDA | -274.373 | -79.972 | 108.563 | 13.223 | 17.717 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -10.598 |
| EBIT | -274.373 | -79.972 | 108.563 | 13.223 | 7.118 |
| Net financials | -51.387 | -10.953 | -9.436 | -5.208 | -5.267 |
| Profit before tax | -325.760 | -90.925 | 99.127 | 8.015 | 1.851 |
| Tax | -0 | -0 | -8.598 | -0 | -30.297 |
| Net profit | -325.760 | -90.925 | 107.725 | 8.015 | 32.149 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 127.579 | 104.619 | 261.661 | 236.646 | 265.373 |
| Equity | -461.370 | -21.271 | 86.455 | 75.196 | 104.967 |
| Long-term debt | 582.024 | 58.872 | 149.243 | 148.530 | 143.375 |
| Short-term debt | 6.924 | 67.018 | 25.963 | 12.921 | 17.032 |
| Total debt | 588.948 | 125.890 | 175.206 | 161.451 | 160.406 |
EBITDA margin
42.3%
This company
15.8%
Market median
+168% vs market
20212025
Equity ratio
39.6%
This company
38.2%
Market median
+4% vs market
20212025
Return on equity
30.6%
This company
18.4%
Market median
+66% vs market
20212025
Net profit margin
76.7%
This company
8.1%
Market median
+847% vs market
20212025
Asset turnover
0.16×
This company
1.12×
Market median
-86% vs market
20212025
Debt / equity
1.53×
This company
0.62×
Market median
-147% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via CVR / Virk · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via CVR / Virk · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via CVR / Virk · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via CVR / Virk · Period 2020-04-01 – 2021-03-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KP Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (4) | ||
LD Management | Management | 2021 – 2022 |
SG Management | Management | 2017 – 2018 |
LA Management | Management | 2017 – 2018 |
ML Chief Executive Officer | Chief Executive Officer | 2018 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2025 | |
| Former (8) | ||
| Chairman | 2018 – 2020 | |
| Chairman | 2021 – 2025 | |
| Board of Directors | 2018 – 2020 | |
| Board of Directors | 2018 – 2020 | |
| Chairman | 2020 – 2021 | |
| Deputy Chairman | 2020 – 2020 | |
| Board of Directors | 2018 – 2019 | |
| Board of Directors | 2020 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2021 | |
| Individual | 100% | 66.67–89.99% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Little Green Pharma Denmark ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lone Dalsgaard | Management | 0 companies |
| Stig Gamborg | Management | 0 companies |
| Lars Allan Thomassen | Management | 0 companies |
| Morten Larsen Snede | Chief Executive Officer | 0 companies |
| Kennet Poulsen | Chief Executive Officer | 0 companies |
| Phillip Stephen Shaer | Chairman | 0 companies |
| Paul Frederick Long | Chairman | 0 companies |
| Angus McDougall Caithness | Chairman | 0 companies |
| David Clifford Pryce | Board of Directors | 0 companies |
| Mark Anthony Nichols Zekulin | Board of Directors | 0 companies |
| Paul Steckler | Chairman | 0 companies |
| Erik Storgaard | Deputy Chairman | 0 companies |
| Pierre Charles Debs | Board of Directors | 0 companies |
| Trine Katborg Davidsen | Board of Directors | 0 companies |